A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 108
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SHD
Long Form : structural heart disease
No. Year Title Co-occurring Abbreviation
2020 Cardiac arrhythmias in pregnant women: need for mother and offspring protection. AADs, AF, CHD
2020 CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography. CMR, OR, VEBs
2020 Focal Ventricular Tachycardias in Structural Heart Disease: Prevalence, Characteristics, and Clinical Outcomes After Catheter Ablation. ATP, LV, RV, VT
2020 Functional Atrial Endocardial-Epicardial Dissociation in Patients With StructuralHeart Disease Undergoing Cardiac Surgery. EGMs, FEED, PES
2020 Outcome of catheter ablation of non-reentrant ventricular arrhythmias in patients with and without structural heart disease. DCM, VA
2020 Outcome of rescue ablation in patients with refractory ventricular electrical storm requiring mechanical circulation support. ES, MCS, VAs
2020 Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice : A state-of-the-art review by the American College of Cardiology Electrophysiology Council. LV, PVCs
2020 Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmias. AAs, BCSD, CSD, ICD, LAVI, OHT, VTs
2020 Risk stratification for cardiac mortality using electrocardiographic markers based on 24-hour Holter recordings: the JANIES-SHD study. CI, ECG, HRT, JANIES study, LVEF, NSVT
10  2020 Structural Heart Disease Emergencies. ---
11  2020 The electrocardiogram of ventricular capture during transcutaneous cardiac pacing. ECG, QTc, TCP, TVP
12  2020 The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic. COVID-19
13  2020 Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement. COVID-19
14  2020 Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement. COVID-19
15  2019 A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in AsianSubjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. AF, AUC, CAD, HF
16  2019 Advancement in cardiac imaging for treatment of ventricular arrhythmias in structural heart disease. EAM, VT
17  2019 Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: A systematic review. CSD, VAs
18  2019 Catheter ablation of polymorphic ventricular tachycardia/fibrillation in patients with and without structural heart disease. PMVT/VF, PVCs, SMVT
19  2019 Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project. CB, PAF, PerAF, PVI
20  2019 Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: An Evaluation of Cohorts With and Without Structural Heart Disease. CB, LV, PAF, PVI
21  2019 Current status and future perspective of structural heart disease intervention. AS, MR, TAVI, TR
22  2019 Electrophysiologic effects and outcomes of sympatholysis in patients with recurrent ventricular arrhythmia and structural heart disease. CSD, CSNRT, OHT, SD, SGB, VA, VT
23  2019 Etiology and Outcomes of Syncope in Patients With Structural HeartDisease and Negative Electrophysiology Study. EPS, HUTT, ILR, NTG
24  2019 Feasibility and performance of catheter ablation with zero-fluoroscopy approach for regular supraventricular tachycardia in patients with structural and/or congenital heart disease. AFL, AP, AT, AVNRT, NSHD, SVTs, ZF-CA
25  2019 Role of Cardiac Magnetic Resonance Imaging in Patients with Idiopathic Ventricular Arrhythmias. CMR, VAs
26  2019 The effect of beta-blockers on foetal birth weight in pregnancies in women with structural heart disease: a prospective cohort study. BBs, FBW, LBW, SGA
27  2019 Three-dimensional printing in structural heart disease and intervention. LAA
28  2019 Very long-term prognosis in patients with right ventricular apical pacing for sick sinus syndrome. AF, CEs, LVEF, RV, SSS
29  2018 A QRS axis-based algorithm to identify the origin of scar-related ventricular tachycardia in the 17-segment American Heart Association model. ECG, SgO, VT
30  2018 A Randomized Trial of Pocket-Echocardiography Integrated Mobile Health Device Assessments in Modern Structural Heart Disease Clinics. mHealth
31  2018 Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry. VT
32  2018 Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study. AAD, AF, CI, HR, Pers, PVI
33  2018 Comparison of Complications of Catheter Ablation for Ventricular Arrhythmias in Adults With Versus Without Structural Heart Disease. CA, OR, VA
34  2018 Diagnostic Utility of High Sensitivity Troponins for Echocardiographic Markers of Structural Heart Disease. CT, hs-troponins, LVH, LVHEcho, NT-proBNP
35  2018 Echocardiography in Transcatheter Structural Heart Disease Interventions. ---
36  2018 High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia. ARVC, CMR, HCM, HR-LGE, ICM, LGE, NICM, NSVT, VA, VF/SCD, VT
37  2018 Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter AblationofVentricular Tachycardia. AAD, ICM, VT
38  2018 Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. CI, RR, VA, VT
39  2018 Predictors of appropriate ICD therapy in Japanese patients with structural heart diseases: A major role of prior sustained ventricular tachycardia in secondary prevention. CRT-D, EF, ICD, SCD
40  2018 Reversal of premature ventricular complexes induced cardiomyopathy. Influence of concomitant structural heart disease. EF, LV, PVC-CM, PVCs, RF
41  2018 Spectrum and Outcome of Patients Who Have Undergone Implantation of an Implantable Cardioverter Defibrillator After Aborted-Sudden Cardiac Arrest. ICD, SCA
42  2018 The safety of catheter ablation for premature ventricular contractions in patients without structural heart disease. PVCs, RVOT
43  2018 Value of implantable loop recorders in patients with structural or electrical heart disease. ILR, IPAS
44  2018 Ventricular arrhythmias originating from the cardiac crux and the basal inferior segment of the interventricular septum in the patients with structural heart diseases: characteristics, mapping, and electrophysiological properties. EGM, IVS, LV, RV, VAs
45  2017 A Comparison of Women and Men Undergoing Catheter Ablation for Sustained Monomorphic Ventricular Tachycardia. ARVC, CA, CAD, NICM, VT
46  2017 A meta-analysis of manual versus remote magnetic navigation for ventricular tachycardia ablation. MAN, RMN, VT
47  2017 Assessment of a novel transdermal selective beta1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease. ECGs, HR, NP-PVCs, PVCs
48  2017 Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implantable cardioverter defibrillators: Vulnerable patients to air pollution. ICD, VF, VTAs
49  2017 Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis. AF, ANP, BNP, IL-6, LDL, NT-proBNP, RFCA, TIMP-2
50  2017 Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. CSD, ICD, VT
51  2017 Early repolarization is associated with a significantly increased risk of ventricular arrhythmias and sudden cardiac death in patients with structural heart diseases. CIs, ERP, OR, SCD, VTAs
52  2017 Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients. LVEF, VT
53  2017 Preliminary study of the application of transthoracic echocardiography-guided three-dimensional printing for the assessment of structural heart disease. VSD
54  2017 Scar characteristics derived from two- and three-dimensional reconstructions of cardiac contrast-enhanced magnetic resonance images: Relationship to ventricular tachycardia inducibility and ablation success. CE-MRI, LGE, LV, SIs, VT
55  2017 Structural Heart Disease Intervention: The Canadian Landscape. ---
56  2017 The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function. LVEF, PVC
57  2017 Value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with frequent premature ventricular complexes undergoing radiofrequency ablation. ICD, MRI, PVCs, VT
58  2017 [Initial study of transthoracic echocardiography guided three-dimensional printing on the application of assessment of structural heart disease]. VSD
59  2016 A New Combined Parameter to Predict Premature Ventricular Complexes Induced Cardiomyopathy: Impact and Recognition of Epicardial Origin. EPI, PVC-CMP
60  2016 Catheter Ablation of Ventricular Tachycardia in the Presence of an Old Endocavitary Thrombus Guided by Intracardiac Echocardiography. ICE, LV, TTE, VT
61  2016 Clinical use of echocardiography in structural heart disease. ---
62  2016 Complications of Cardiac Catheterization in Structural Heart Disease. OR
63  2016 Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis. CI, ECHO, HD, HR, LVEF, RV
64  2016 Long-Term Results After Single and Multiple Procedures of Ablation of Ventricular Tachycardia. VT
65  2016 Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients. VA
66  2016 Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR. AF, AFL
67  2016 Syncope in patients paced for atrioventricular block. AVB
68  2015 Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. DE, LA
69  2015 Catheter ablation of atrial fibrillation in patients with atrial septal defect: long-term follow-up results. AF, ASD
70  2015 Hybrid Imaging During Transcatheter Structural Heart Interventions. ---
71  2015 Management of ventricular arrhythmias in structural heart disease. CA, ICD, VA
72  2015 Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach. CA, ICD, VT
73  2015 Predicting the outcome in patients with unexplained syncope and suspected cardiac cause: role of electrophysiologic studies. EP, HUTT, LBBB, LV
74  2015 Prevalence and clinical significance of cardiac murmurs in schoolchildren. CHD
75  2014 Changes to the cardiac biomarkers of non-elite athletes completing the 2009 London Marathon. BNP, HSTnT, TnI, TnT
76  2014 Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry. AF, CA, CAD, CI, CM, HHD, OR, OR
77  2014 Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. ICD, LVEF, SD, SMVT
78  2014 [Transesophageal and intracardiac echocardiography in therapeutic cardiac catheterizations of structural heart disease]. CC, ICE, TEE
79  2013 Atrial fibrillation in young stroke patients: do we underestimate its prevalence? AF, AF-NSHD, IS, mRS, NIHSS
80  2013 Implantable loop recorder allows an etiologic diagnosis in one-third of patients. Results of the Spanish reveal registry. BBB, ILR
81  2013 Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset. AF, CRP, LAF, PAF
82  2013 Integrated x-ray and echocardiography imaging for structural heart interventions. TEE
83  2013 Multiple accessory pathways in the young: the impact of structural heart disease. MultAP
84  2013 Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. LV, PVC, SSA
85  2013 Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation. AF, ERP, LA, PAF, PeAF, RFCA, SND
86  2011 Case fatality in children with supraventricular tachycardia in the United States. SVT
87  2011 Effects of chronic amiodarone on the electrical restitution in the human ventricle with reference to its antiarrhythmic efficacy. RVOT
88  2011 Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. AF, CI, OR, VT
89  2011 Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. AF, PVAI
90  2011 Presence of structural heart disease and left ventricular dysfunction predict hospitalizations for new-onset heart failure after right ventricular apical pacing. CI, HF, HR, LV, LVEF, PMIs, QRSd, RVAP
91  2010 Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation. AF, PIP
92  2010 Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. ACC, AF, AHA, ESC, RecordAF
93  2010 Structural heterogeneity alone is a sufficient substrate for dynamic instability and altered restitution. ---
94  2010 Syncope and structural heart disease: historical criteria for vasovagal syncope and ventricular tachycardia. VT, VVS
95  2010 The SCAI Structural Heart Disease Council: toward addressing training, credentialing, and guidelines for structural heart disease intervention. ---
96  2009 Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers. AF, SND
97  2008 Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease. ILR
98  2008 Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width. HF, LVSD, NT-proBNP, PCP
99  2008 Structural heart disease in children in Lagos: profile, problems and prospects. AHD, CHD
100  2008 Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. ICMP, NICMP, VT